Ageing Research Reviews, Год журнала: 2024, Номер unknown, С. 102639 - 102639
Опубликована: Дек. 1, 2024
Язык: Английский
Ageing Research Reviews, Год журнала: 2024, Номер unknown, С. 102639 - 102639
Опубликована: Дек. 1, 2024
Язык: Английский
Translational Neurodegeneration, Год журнала: 2024, Номер 13(1)
Опубликована: Сен. 4, 2024
Язык: Английский
Процитировано
15Translational Neurodegeneration, Год журнала: 2024, Номер 13(1)
Опубликована: Авг. 6, 2024
Abstract The deposition of abnormal tau protein is characteristic Alzheimer’s disease (AD) and a class neurodegenerative diseases called tauopathies. Physiologically, maintains an intrinsically disordered structure plays diverse roles in neurons. Pathologically, undergoes post-translational modifications forms oligomers or fibrous aggregates In this review, we briefly introduce several tauopathies discuss the mechanisms mediating aggregation propagation. We also describe toxicity pathology. Finally, explore early diagnostic biomarkers treatments targeting tau. Although some encouraging results have been achieved animal experiments preclinical studies, there still no cure for More in-depth basic clinical research on pathogenesis necessary.
Язык: Английский
Процитировано
6Trends in Immunology, Год журнала: 2024, Номер unknown
Опубликована: Сен. 1, 2024
Язык: Английский
Процитировано
5Current Opinion in Genetics & Development, Год журнала: 2025, Номер 91, С. 102324 - 102324
Опубликована: Фев. 20, 2025
Язык: Английский
Процитировано
0Gene, Год журнала: 2024, Номер 931, С. 148854 - 148854
Опубликована: Авг. 13, 2024
Язык: Английский
Процитировано
0Sensors and Actuators B Chemical, Год журнала: 2024, Номер 423, С. 136750 - 136750
Опубликована: Окт. 9, 2024
Язык: Английский
Процитировано
0Mammalian Genome, Год журнала: 2024, Номер unknown
Опубликована: Окт. 26, 2024
There is a thriving, worldwide, biomedical research community working to understand the molecular bases of diseases all types, continuously driving improved diagnostics and therapies. Developments in genetics experimental medicine are yielding novel genetic therapies that were hardly dreamt 40 years ago. But along with these scientific achievements, there exist challenges ensuring 21st century medical interventions accessible who need them. This perspective will discuss how preclinical research, focus on rare diseases, can better contribute healthcare ecosystems oriented towards greater health equity. contribution may require changes prevailing culture support from relevant institutions wider community.
Язык: Английский
Процитировано
0Ageing Research Reviews, Год журнала: 2024, Номер unknown, С. 102639 - 102639
Опубликована: Дек. 1, 2024
Язык: Английский
Процитировано
0